Joseph A Mollica's Net Worth
$7.04 Million
Who is Joseph A Mollica?
Joseph A Mollica has an estimated net worth of $7.04 Million. This is based on reported shares across multiple companies, which include GENENCOR INTERNATIONAL INC, PHARMACOPEIA DRUG DISCOVERY INC, NEUROCRINE BIOSCIENCES INC, Celator Pharmaceuticals Inc, Redpoint Bio CORP, PHARMACOPEIA INC, and CYTOGEN CORP.
SEC CIK
Joseph A Mollica's CIK is 0001126489
Past Insider Trading and Trends
2007 was Joseph A Mollica's most active year for acquiring shares with 22 total transactions. Joseph A Mollica's most active month to acquire stocks was the month of April. 2007 was Joseph A Mollica's most active year for disposing of shares, totalling 42 transactions. Joseph A Mollica's most active month to dispose stocks was the month of February. 2004 saw Joseph A Mollica paying a total of $868,799.91 for 47,096.51 shares, this is the most they've acquired in one year. In 2014 Joseph A Mollica cashed out on 52,739 shares for a total of $280,735.05, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GENENCOR INTERNATIONAL INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
| No matching records found | |||||||||
PHARMACOPEIA DRUG DISCOVERY INC No price found
Chairman, Interm-President/CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -141.98K |
—
|
—
|
0
|
Dec 23
| |||
Form 4
| +0.80% | 1.12K |
$0.87 | $978.74 | 141.98K |
Oct 31
| |||
Form 4
| +0.48% | 679.54 |
$1.49 | $1,012.51 | 140.85K |
Sep 30
| |||
Form 4
| +0.35% | 482.15 |
$2.10 | $1,012.52 | 140.17K |
Aug 29
| |||
Form 4
| +0.22% | 309.63 |
$3.27 | $1,012.49 | 139.69K |
Jul 31
| |||
Form 4
| +0.30% | 414.16 |
$3.83 | $1,586.23 | 139.38K |
Jun 30
| |||
Form 4
| +0.19% | 266.24 |
$4.31 | $1,147.49 | 138.97K |
May 30
| |||
Form 4
| +65.71% | 55K |
—
|
—
| 138.7K |
May 7
| |||
Form 4
|
—
|
0
|
$4.21 | -$23,326.54 | 83.7K |
Sep 10
| |||
Form 4
|
—
|
0
|
$4.28 | -$14,536.50 | 83.7K |
Sep 6
| |||
Form 4
|
—
|
0
|
$4.22 | -$41,774.50 | 83.7K |
Sep 4 - Sep 5
| |||
Form 4
|
—
|
0
|
$4.24 | -$282.73 | 83.7K |
Aug 30
| |||
Form 4
|
—
|
0
|
$4.18 | -$1,363.65 | 83.7K |
Aug 29
| |||
Form 4
|
—
|
0
|
$4.19 | -$27,377.00 | 83.7K |
Aug 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
$4.04 | -$24,373.00 | 83.7K |
Mar 15
| |||
Form 4
|
—
|
0
|
$3.95 | -$22,592.00 | 83.7K |
Mar 14
| |||
Form 4
|
—
|
0
|
$4.01 | -$47,348.00 | 83.7K |
Mar 12 - Mar 13
| |||
Form 4
|
—
|
0
|
$4.06 | -$12,387.50 | 83.7K |
Mar 9
| |||
Form 4
|
—
|
0
|
$3.81 | -$29,592.50 | 83.7K |
Mar 7 - Mar 8
| |||
Form 4
| -0.06% | -54.00 |
$4.60 | -$248.40 | 83.7K |
Mar 1
| |||
Form 4
| -0.26% | -217.00 |
$4.78 | -$1,037.26 | 83.75K |
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
$2.78 | -$15,571.76 | 83.97K |
Mar 9
| |||
Form 4
|
—
|
0
|
$2.78 | -$42,995.51 | 83.97K |
Mar 7 - Mar 8
| |||
Form 4
| -1.87% | -1.60K |
$5.60 | -$8,964.31 | 83.97K |
Nov 23
| |||
Form 4
| +0.14% | 122.13 |
$6.96 | $850.02 | 85.57K |
May 28
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $120.17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +50.03% | 18.69K |
$27.60 | $38.40 | 56.04K |
Apr 12
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| +94.81% | 18.18K |
$18.39 | $32.30 | 37.35K |
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
| +446.61% | 15.67K |
$13.36 | $3.99 | 19.18K |
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +83.28% | 1.59K |
$13.11 | $10.96 | 3.51K |
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
∞
| 1.91K |
$11.38 | $5.10 | 1.91K |
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Celator Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Redpoint Bio CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||